These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25703057)

  • 1. The biological basis for poly-L-lactic acid-induced augmentation.
    Stein P; Vitavska O; Kind P; Hoppe W; Wieczorek H; Schürer NY
    J Dermatol Sci; 2015 Apr; 78(1):26-33. PubMed ID: 25703057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen Stimulators: Poly-L-Lactic Acid and Calcium Hydroxyl Apatite.
    Breithaupt A; Fitzgerald R
    Facial Plast Surg Clin North Am; 2015 Nov; 23(4):459-69. PubMed ID: 26505542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late-onset immune-mediated adverse effects after poly-L-lactic acid injection in non-HIV patients: clinical findings and long-term follow-up.
    Alijotas-Reig J; Garcia-Gimenez V; Vilardell-Tarres M
    Dermatology; 2009; 219(4):303-8. PubMed ID: 19797889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly-L-lactic acid: a new dimension in soft tissue augmentation.
    Rotunda AM; Narins RS
    Dermatol Ther; 2006; 19(3):151-8. PubMed ID: 16784514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly-L-Lactic acid increases collagen gene expression and synthesis in cultured dermal fibroblast (Hs68) through the TGF-β/Smad pathway.
    Zhu W; Dong C
    J Cosmet Dermatol; 2023 Apr; 22(4):1213-1219. PubMed ID: 36575891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimizing adverse events associated with poly-L-lactic acid injection.
    Narins RS
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S100-4. PubMed ID: 18547172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigator global evaluations of efficacy of injectable poly-L-lactic acid versus human collagen in the correction of nasolabial fold wrinkles.
    Brandt FS; Cazzaniga A; Baumann L; Fagien S; Glazer S; Kenkel JM; Lowe NJ; Monheit GD; Narins RS; Rendon MI; Rohrich RJ; Werschler WP
    Aesthet Surg J; 2011 Jul; 31(5):521-8. PubMed ID: 21719865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly-L-lactic acid injection for HIV-associated facial lipoatrophy: treatment principles, case studies, and literature review.
    Kates LC; Fitzgerald R
    Aesthet Surg J; 2008; 28(4):397-403. PubMed ID: 19083552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsurgical rejuvenation of the aging face with injectable poly-L-lactic acid for restoration of soft tissue volume.
    Schierle CF; Casas LA
    Aesthet Surg J; 2011 Jan; 31(1):95-109. PubMed ID: 21239677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cosmetic use of poly-l-lactic acid: a retrospective study of 130 patients.
    Palm MD; Woodhall KE; Butterwick KJ; Goldman MP
    Dermatol Surg; 2010 Feb; 36(2):161-70. PubMed ID: 20039924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-onset subcutaneous nodules after poly-L-lactic acid injection.
    Reszko AE; Sadick NS; Magro CM; Farber J
    Dermatol Surg; 2009 Feb; 35 Suppl 1():380-4. PubMed ID: 19207329
    [No Abstract]   [Full Text] [Related]  

  • 12. Single-arm study for the characterization of human tissue response to injectable poly-L-lactic acid.
    Goldberg D; Guana A; Volk A; Daro-Kaftan E
    Dermatol Surg; 2013 Jun; 39(6):915-22. PubMed ID: 23464798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pro-fibrotic properties of transforming growth factor on human fibroblasts are counteracted by caffeic acid by inhibiting myofibroblast formation and collagen synthesis.
    Mia MM; Bank RA
    Cell Tissue Res; 2016 Mar; 363(3):775-89. PubMed ID: 26453399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Composition and mechanism of action of poly-L-lactic acid in soft tissue augmentation.
    Vleggaar D; Fitzgerald R; Lorenc ZP
    J Drugs Dermatol; 2014 Apr; 13(4 Suppl):s29-31. PubMed ID: 24719074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semipermanent filler treatment of HIV-positive patients with facial lipoatrophy: long-term follow-up evaluating MR imaging and quality of life.
    van Rozelaar L; Kadouch JA; Duyndam DA; Nieuwkerk PT; Lutgendorff F; Karim RB
    Aesthet Surg J; 2014 Jan; 34(1):118-32. PubMed ID: 24334306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles.
    Narins RS; Baumann L; Brandt FS; Fagien S; Glazer S; Lowe NJ; Monheit GD; Rendon MI; Rohrich RJ; Werschler WP
    J Am Acad Dermatol; 2010 Mar; 62(3):448-62. PubMed ID: 20159311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiochemical Characteristics of Poly-L-Lactic Acid (PLLA).
    Fitzgerald R; Bass LM; Goldberg DJ; Graivier MH; Lorenc ZP
    Aesthet Surg J; 2018 Apr; 38(suppl_1):S13-S17. PubMed ID: 29897517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Satisfying patient expectations with poly-L-lactic acid soft tissue augmentation.
    Vleggaar D; Fitzgerald R; Lorenc ZP
    J Drugs Dermatol; 2014 Apr; 13(4 Suppl):s40-3. PubMed ID: 24719077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biostimulatory effects of polydioxanone, poly-d, l lactic acid, and polycaprolactone fillers in mouse model.
    Kwon TR; Han SW; Yeo IK; Kim JH; Kim JM; Hong JY; Lee BC; Lee SE; Moon HS; Kwon HJ; Kim BJ
    J Cosmet Dermatol; 2019 Aug; 18(4):1002-1008. PubMed ID: 30985064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The history behind the use of injectable poly-L-lactic acid for facial and nonfacial volumization: the positive impact of evolving methodology.
    Vleggaar D; Fitzgerald R; Lorenc ZP
    J Drugs Dermatol; 2014 Apr; 13(4 Suppl):s32-4. PubMed ID: 24719075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.